Aravive to Participate in Upcoming Virtual Investor Conferences in September

    NEXT STORY
    Corbus Pharmaceuticals Announces Topline Results from RESOLVE-1 Phase 3 Study of Lenabasum for Treatment of Systemic Sclerosis
    PREV STORY
    Biopharma Leaders Unite to Stand with Science
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Sandoz Canada Launches a New Concentration of T/CLorazepam Injection USP

    Lire la version française BOUCHERVILLE, Quebec, Dec. 2, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada ...

    author_avatar
    NASDAQ Market News

    Vical to Present at IDWeek and the 8th Trends in Medical Mycology Conferences

    SAN DIEGO, Sept. 28, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) announced today that ...

    author_avatar
    NASDAQ Market News

    IMV (Formerly Immunovaccine Inc.) to Present at the National Bank Financial Quebec Conference in Toronto

    HALIFAX, Nova Scotia, May 25, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (TSX:IMV) (OTCQX:IMMVF), a ...

    author_avatar
    NASDAQ Market News